Diagnostic and Interventional Therapy in Acute Pancreatitis
1 other identifier
observational
50
1 country
1
Brief Summary
The study aims to evaluate the course of patients with acute pancreatitis. Thereby we analyze different diagnostics and compare ultrasound, MRI and CT-scan in detection of necrotic areas and evaluate interventional therapy methods like percutaneous drainage techniques regarding the outcome. Laboratory values were assessed as well.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
June 13, 2008
CompletedFirst Posted
Study publicly available on registry
June 18, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedAugust 9, 2011
June 1, 2010
4.6 years
June 13, 2008
August 8, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Length of hospital stay
weekly
Secondary Outcomes (3)
time to surgery
weekly
active necrosectomy
weekly
ICU stay
weekly
Study Arms (1)
1
Evaluation of one study cohort
Interventions
Evaluation of different diagnostics and evaluation of outcome of patients who received percutaneous CT-guided drainage for necrotic debridement and analyze the further outcome
Eligibility Criteria
50 patients with acute pancreatitis
You may qualify if:
- Age \> 18 years
- Acute pancreatitis
- Written formal consent
You may not qualify if:
- Pregnancy
- Missing formal consent
- Individual contraindications for CT-scan
- MRI or endoscopic ultrasound
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Internal medicine I, University of Regensburg
Regensburg, 93053, Germany
Biospecimen
Bacterial DNA
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jürgen Schölmerich, Prof.
Director of Department of Internal Medicine I
- STUDY DIRECTOR
Stefan Feuerbach, Prof.
Director of Department of Radiology
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 13, 2008
First Posted
June 18, 2008
Study Start
May 1, 2008
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
August 9, 2011
Record last verified: 2010-06